CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Impact of Renal Function on the Pharmacokinetics of Hydroxyurea (SIKLOS ®) in Normal-renal Function, Hyperfiltrating and Renal Failure Sickle Cell Disease Patients (DARH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02522104
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:26.989201+00:00
Published At: 2021-08-27T00:00:00+00:00
Record Updated At: 2021-10-12
Results Posted At: 2021-08-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sickle Cell Disease", "Renal Function Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-10-12"
protocolSection.identificationModule.nctId: "NCT02522104"
protocolSection.identificationModule.officialTitle: "Evaluation of the Impact of Renal Function on the Pharmacokinetics of Hydroxyurea (SIKLOS \u00ae) in Normal-renal Function, Hyperfiltrating and Renal Failure Sickle Cell Disease Patients (DARH)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-08-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.